-
Document de presse | 2012.02.23
New cancer target identified?
A team of researchers from the Institut Pasteur and the CNRS has recently identified a protein that can specifically control the activity of an enzyme whose dysfunction has been linked to the development of several types of cancer. This work reveals a potential therapeutic target for the treatment of certain tumors. This study is being published today in the scientific journal Molecular Cell....
-
Document de presse | 2011.03.06
Powerful human DNA mutators identified
Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the French National Institute for Health and Medical Research (Inserm) have shown that a cellular protein, APOBEC3A, known for its antiviral activity, is also capable of mutagenic activity on human cell DNA. This discovery suggests that this protein plays a role in the cellular DNA degradation...
-
Document de presse | 2010.09.19
Bacteria disseminate resistance even in the absence of antibiotics
Institut Pasteur researchers in the Antibacterial Agents Unit, directed by Patrice Courvalin, studied resistance to vancomycin in enterococcus bacteria and demonstrated why the mechanism of resistance to this antibiotic has spread so effectively throughout the world. It was previously believed that only large-scale antibiotic use would be responsible for the resistance spread. However, this study...
-
Document de presse | 2010.02.14
Customized stem cells to help treat leukemia?
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS) have just discovered the origin of hematopoietic stem cells (HSC), which give rise to all blood and immune cells in the body. Using real-time imaging technology on zebrafish embryos, the researchers observed that these stem cells were formed from the cells of the aortic wall, the embryo's main...
-
Document de presse | 2009.02.04
A yeast for studying neurodegenerative diseases
A team from the Institut Pasteur working with the CNRS (French National Center for Scientific Research) has shown in an article published in the EMBO Journal that a yeast can be used as a cell model for a rare and severe neurodegenerative disease affecting adolescents. This discovery could provide researchers with an unexpected and particularly effective tool for studying the genetics of this...
-
Document de presse | 2008.07.07
Whooping cough: bacterial monitoring for better prevention
Researchers from the Institut Pasteur in Paris and the Institut Pasteur in Lille have analyzed the consequences of intensive vaccination of young children against whooping cough on the bacterium agent of the disease. Their observations highlight the importance of continuing bacterial evolution in order to adapt vaccine strategies. Press release Paris, july 8, 2008 ...
-
Document de presse | 2006.06.25
Hereditary deafness - Discovery of a gene essential for a proper communication between the ear and the brain
Professor Christine Petit's team at the Institut Pasteur Genetics of Sensory Defects Unit, in collaboration with INSERM* and the Collège de France, has recently identified mutations in a gene which, contrary to all other mutations of the deafness genes identified to date, do not cause a dysfunction in the auditory sensory organ, the cochlea. Based on the development of a mouse model, the...
-
Document de presse | 2005.10.12
Institut Pasteur and Total join forces to combat infectious diseases
On October 13, Total and Institut Pasteur signed a corporate funding agreement intended to strengthen the scientific and human resources allocated to the fight against infectious diseases, especially sexually transmitted diseases (STD). The five-year agreement covers two areas. Press release Paris, october 13, 2005 · Support for Institut Pasteur’s research...
-
Document de presse | 2005.06.27
Gates millions for vaccine research The fight against hepatitis C and HIV: foundation supports international consortium
The Bill and Melinda Gates Foundation (Seattle, USA) has decided to fund an international research consortium led by the German Research Centre of Biotechnology (GBF) in Braunschweig and the Institut Pasteur in Paris. The long-term goal of the 9 million dollar project is the development of vaccines against Hepatitis C and HIV. Press release Paris, june 28, 2005 “...
-
Document de presse | 2005.06.23
INRS–Institut Armand-Frappier (Canada) Joins the Réseau International des Instituts Pasteur And Supports Global Appeal to Boost Attention to Neglected Diseases
The INRS–Institut Armand-Frappier research centre, located in Laval, close to Montreal (Canada), recently joined the Réseau International des Instituts Pasteur (RIIP) which now has 29 member institutions on five continents. The INRS–Institut Armand-Frappier research centre is the first North American institution to join the RIIP network. Press release Paris, june 24,...